Statin drugs for "hypercholesterolemia," which some doctors call a non-illness, have become more potent and are being prescribed in higher doses to increasing numbers of people--even those with "normal" cholesterol levels. What is often overlooked by physicians is that patients taking statins become depleted in Coenzyme Q10 (CoQ10), which leads to fatigue, muscle weakness, soreness and heart failure.
A petition to label statin packages with a warning about statin-induced CoQ10 depletion has been issued to the U.S. Food and Drug Administration (FDA), along with a review of animal and human studies supporting the issue. However, experts fear that the warning will not gain the attention it deserves.
Red Flags Daily July 10, 2003